Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Breaking News

Kosher-Certified Marijuana Products Are Hitting the Market in 2016

A New York company is preparing to market what it says is the world’s first kosher-certified marijuana.

The Orthodox Union has certified Vireo Health of New York’s non-smokable medical marijuana products, Vireo announced in a news release Wednesday. Vireo is one of five medical marijuana providers selected to participate in a New York state medical marijuana program that goes into effect next month; none of the others will be certified kosher.

“Being certified kosher by the OU will not only help us serve the dietary needs of the largest Jewish community in the United States, but also combat unfortunate stigmas associated with medical cannabis,” Vireo CEO Ari Hoffnung said in a statement. “Today’s announcement sends an important message to New Yorkers of all faiths and backgrounds that using medical cannabis to alleviate pain and suffering does not in any way represent an embrace of ‘pot’ culture.”

Rabbi Menachem Genack, CEO of the O.U.’s kashrut department, said in a statement that Vireo’s medical cannabis products “were developed to alleviate pain and suffering in accordance with the New York State Compassionate Care Act.”

The statement adds, “Using medical cannabis products recommended by a physician should not be regarded as a ‘chet,’ a sinful act, but rather as a mitzvah, an imperative, a commandment.”

Vireo operates a facility in the upstate town of Perth and will open four retail dispensaries in January, including two in the New York City area.

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Foward. Have questions? Please email us at help@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.